Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Caillaud

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Angewandte Chemie (International Ed. in English)|October 25, 2016
Design of Potent Mannose 6-Phosphate Analogues for the Functionalization of Lysosomal Enzymes To Improve the Treatment of Pompe DiseaseKhaled El Cheikh, Ilaria Basile, Afitz Da Silva, et al.
Plos One|August 13, 2013
A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 Gaucher disease patientsSéverine Lecourt, Enguerran Mouly, Delphine Freida, et al.
Brain & Development|March 24, 2010
A French experience of type 3 Gaucher disease: Phenotypic diversity and neurological outcome of 10 patientsIchraf Kraoua, Frédéric Sedel, Catherine Caillaud, et al.
La Tunisie Medicale|April 27, 2010
[Phenotype and mutational spectrum in Tunisian pediatric gaucher disease]Hadhami Ben Turkia, Imène Riahi, Hatem Azzouz, et al.
Journal of Cellular and Molecular Medicine|July 12, 2019
Mannose 6-phosphonate labelling: A key for processing the therapeutic enzyme in Pompe diseaseAnastasia Godefroy, Morgane Daurat, Afitz Da Silva, et al.
European Journal of Neurology|May 2, 2024
Ceroid lipofuscinosis type 2 disease: Effective presymptomatic therapy-Oldest case of a presymptomatic enzyme therapyDelphine Breuillard, Lisa Ouss, Marie Thérèse Le Normand, et al.
Molecular Genetics and Metabolism|January 29, 2023
Plasma G<sub>M2</sub> ganglioside potential biomarker for diagnosis, prognosis and disease monitoring of GM2-GangliosidosisAmélie Blondel, Ichraf Kraoua, Chloé Marcelino, et al.
Cellular & Molecular Biology Letters|April 9, 2026
Restoration of lysosomal membrane integrity in cell models of Pompe disease depends on fatty acid synthase and its product palmitic acidEdouard Le Guillou, Arianna Segaloni, Alexis Gadault, et al.
Blood Cells, Molecules & Diseases|June 26, 2009
Gaucher disease in Tunisia: High frequency of the most common mutationsWafa Cherif, Hadhami Ben Turkia, Faten Ben Rhouma, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 8, 2017
Efficient therapy for refractory Pompe disease by mannose 6-phosphate analogue grafting on acid α-glucosidaseIlaria Basile, Afitz Da Silva, Khaled El Cheikh, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Angewandte Chemie (International Ed. in English)|October 25, 2016
Design of Potent Mannose 6-Phosphate Analogues for the Functionalization of Lysosomal Enzymes To Improve the Treatment of Pompe DiseaseKhaled El Cheikh, Ilaria Basile, Afitz Da Silva, et al.
Plos One|August 13, 2013
A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 Gaucher disease patientsSéverine Lecourt, Enguerran Mouly, Delphine Freida, et al.
Brain & Development|March 24, 2010
A French experience of type 3 Gaucher disease: Phenotypic diversity and neurological outcome of 10 patientsIchraf Kraoua, Frédéric Sedel, Catherine Caillaud, et al.
La Tunisie Medicale|April 27, 2010
[Phenotype and mutational spectrum in Tunisian pediatric gaucher disease]Hadhami Ben Turkia, Imène Riahi, Hatem Azzouz, et al.
Journal of Cellular and Molecular Medicine|July 12, 2019
Mannose 6-phosphonate labelling: A key for processing the therapeutic enzyme in Pompe diseaseAnastasia Godefroy, Morgane Daurat, Afitz Da Silva, et al.
European Journal of Neurology|May 2, 2024
Ceroid lipofuscinosis type 2 disease: Effective presymptomatic therapy-Oldest case of a presymptomatic enzyme therapyDelphine Breuillard, Lisa Ouss, Marie Thérèse Le Normand, et al.
Molecular Genetics and Metabolism|January 29, 2023
Plasma G<sub>M2</sub> ganglioside potential biomarker for diagnosis, prognosis and disease monitoring of GM2-GangliosidosisAmélie Blondel, Ichraf Kraoua, Chloé Marcelino, et al.
Cellular & Molecular Biology Letters|April 9, 2026
Restoration of lysosomal membrane integrity in cell models of Pompe disease depends on fatty acid synthase and its product palmitic acidEdouard Le Guillou, Arianna Segaloni, Alexis Gadault, et al.
Blood Cells, Molecules & Diseases|June 26, 2009
Gaucher disease in Tunisia: High frequency of the most common mutationsWafa Cherif, Hadhami Ben Turkia, Faten Ben Rhouma, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 8, 2017
Efficient therapy for refractory Pompe disease by mannose 6-phosphate analogue grafting on acid α-glucosidaseIlaria Basile, Afitz Da Silva, Khaled El Cheikh, et al.
Pageof 9